Search EDVA
Endovia Health Sciences, Inc.
NYSE · CIK 1553788
Last close0.16
Daily change-0.00 (-1.24%)
10 Years gain-99.94%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
EDVA · STANDARD
SIC 2080 · Beverages · Fiscal year end 1231
Fundamental
19.2Momentum
0.0Acceleration
0.0Confidence
67.0Annual Revenue15
Quarterly Revenue52
Annual CFO15
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.0 / 25
Quality12.5 / 25
Capital Efficiency0.0 / 20
Balance Sheet5.8 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Net debt reductionNet debt declined versus the comparison period.
Warnings
Gross margin compression · MEDIUMGross margin compressed by 32.5253 percentage points.
Operating margin compression · MEDIUMOperating margin compressed by 12276.6101 percentage points.
Heavy share dilution · HIGHDiluted share count increased 134.5315%.
High SBC · MEDIUMStock based compensation is high relative to revenue or FCF.
Low interest coverage · HIGHInterest coverage is -2.5795x.
Key Metrics
Revenue Growth TTM-99.43%OK
Revenue CAGR 3Y-84.07%OK
Gross Margin-9.62%OK
Operating Margin-12,436.53%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFO0.07xOK
Diluted Share Growth 1Y134.53%OK
SBC / Revenue2,982.56%OK
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $73,066.00 | $16,898.00 | -$14.19M | -$4.82M | n/a | 23.13% | -19,415.62% | n/a | n/a | 2.18M |
| 2025 FY Dec 31, 2024 | $801,273.00 | -$119,797.00 | -$9.90M | -$7.30M | n/a | -14.95% | -1,235.59% | n/a | n/a | 1.34M |
| 2024 FY Dec 31, 2023 | $18.85M | $5.57M | -$15.29M | -$10.19M | -$10.20M | 29.54% | -81.1% | -54.13% | -1,271.83% | 1.06M |
| 2023 FY Dec 31, 2022 | $18.09M | $5.92M | -$21.39M | -$14.04M | -$14.14M | 32.72% | -118.28% | -78.19% | -278.94% | 37.39M |
| 2022 FY Dec 31, 2021 | $11.32M | $3.92M | -$29.08M | -$14.70M | -$14.70M | 34.62% | -257.01% | -129.88% | n/a | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $49,424.00 | sum latest 4 fiscal quarters Revenue | OK | 0001731122-26-000769, 0001731122-26-001102 |
| Revenue Growth TTM | -99.43% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001731122-26-000769, 0001731122-26-001102 |
| Revenue CAGR 3Y | -84.07% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001731122-26-000577 |
| Revenue CAGR 5Y | -49.84% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001731122-26-000577 |
| Gross Profit CAGR 3Y | -85.81% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001731122-26-000577 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001731122-26-000769, 0001731122-26-001102 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | -9.62% | Gross Profit / Revenue | OK | 0001731122-26-000769, 0001731122-26-001102 |
| Operating Margin | -12,436.53% | Operating Income / Revenue | OK | 0001731122-26-000769, 0001731122-26-001102 |
| Net Debt / CFO | 0.07x | Net Debt / CFO | OK | 0001731122-26-001102, 0001731122-26-000769 |
| Interest Coverage | -2.58x | Operating Income / abs(Interest Expense) | OK | derived |
| Current Ratio | 0.05x | Current Assets / Current Liabilities | OK | derived |
| SBC / Revenue | 2,982.56% | SBC / Revenue | OK | 0001731122-26-000769, 0001731122-26-001102 |
| Revenue per Diluted Share | $0.02 | Revenue / Diluted Shares | OK | 0001731122-26-000769, 0001731122-26-001102 |